Beckman Coulter Diagnostics appoints Kevin O’Reilly as new president

Feb. 7, 2024
Kevin brings more than 30 years of leadership experience.

Beckman Coulter Diagnostics announced Kevin O’Reilly’s appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive, Danaher Diagnostics.

Most recently, Kevin served as president of Radiation Oncology Solutions at Varian Medical Systems, where he was responsible for more than $3 billion in revenue and 6,500 associates worldwide. Throughout his nearly 15-year tenure with Varian, Kevin led end-to-end solutions for all radiation therapy customers, including R&D and product strategy, supply chain and manufacturing, and all global sales, service, and marketing. Under Kevin’s leadership, Varian achieved record revenue, world-class customer satisfaction and industry-leading associate engagement scores across all regions while growing market share.

Kevin holds an Honors diploma from the Technical University of Ireland and Bachelor of Science in Electrical Engineering from Trinity College.

Beckman Coulter release